Cordis Cardiology Gets Approval for New Coronary Artery Stent

Cordis Cardiology (Miami) has received FDA approval to market its new MINI Crown stent (the MINI) specifically engineered for smaller coronary vessels. Cordis Cardiology is a unit of Cordis Corp., a Johnson & Johnson company.

The company initially will offer the MINI in 11- and 15-mm lengths and diameters ranging from 3.25 to 2.25 mm in quarter sizes.

The MINI is indicated for treatment of abrupt or threatened closure in patients with failed interventional therapy in native coronary lesions (less than or equal to 25 mm) with reference diameters in the range of 3.25 to 2.25 mm.